Intended for healthcare professionals

News

Medicare’s decision not to fund Aduhelm changes landscape for US pharma industry

BMJ 2022; 377 doi: https://doi.org/10.1136/bmj.o996 (Published 19 April 2022) Cite this as: BMJ 2022;377:o996